Kent Buse

Kent BuseKent Buse is a political analyst, strategist and writer. He serves as senior advisor to the Executive Director of UNAIDS and Chief, Strategic Policy Directions. He is a political economist who has taught at Yale University (School of Public Health) and at the London School of Hygiene and Tropical Medicine. He is author/editor of five books including Making Health Policy, Making Sense of Global Health Governance and Thinking Politically about HIV. He has over 100 publications in leading peer-reviewed journals, such as The Lancet, as well as in the popular press around the world. His work covers the politics of health policy, global public-private health partnership, accountability as well as AIDS, sexual and reproductive health and rights, and power evidence in the control of non-communicable diseases. He has worked for and/or advised a range of multi- and bi-lateral organizations, among them UNICEF, WHO, Global Fund, GAIN, PMNCH, DFID and ODI as well as national governments. Kent holds a PhD (London) and an MSc (Econ) (London).

Anders Nordström

Anders NordströmPresently Anders Nordström holds the position as Ambassador for Global Health at the Swedish Ministry for Foreign Affairs in Stockholm. As a medical doctor from the Karolinska Institute, Sweden, Dr Nordström has a background that combines development experience in the field, national and international health policy and planning, and strategic leadership. His first international assignments were with the Swedish Red Cross in Cambodia and the International Committee of the Red Cross in Iran. He worked initially for the Swedish International Development Cooperation Agency (Sida) for 12 years, including three years as Regional Health Advisor in Zambia and four years as Head of the Health Division in Stockholm. During 2002 Dr Nordström was the Interim Executive Director for the Global Fund to Fight AIDS, Tuberculosis and Malaria.Dr Nordström was Assistant Director-General at WHO for General Management from July 2003 and Acting Director-General of WHO from 23 May 2006 until 3 January 2007. After the successful handing over to Dr Margaret Chan, Dr Nordström was appointed Assistant Director-General for Health Systems and Services. From January 2008 until June 2010 Dr Nordström served as Director-General for the Swedish International Agency for Development Cooperation (Sida).  

Anna Mia Ekström 

Anna Mia EkströmAs a senior infectious disease epidemiologist and clinician, my work over the last 14 years has focused on HIV/AIDS. In particular much of my research has concentrated on program implementation for the prevention of mother to child transmission (PMTCT) in resource-limited health systems in sub-Saharan Africa (Kenya, Tanzania, Uganda, Burkina Faso, South Africa). My areas of expertise include Epidemiology, Clinical Infectious Disease Medicine, Public health, Global Health, Health Systems and Maternal health with specific expertise in key research areas for this application including PMTCT, HIV/AIDS care and program implementation. I am a Clinical Professor at the Karolinska Institutet (KI) in Stockholm, Sweden and also clinically active as a specialist in Infectious Diseases and HIV at the Karolinska University Hospital. I hold a Master of Public Health (MPH) degree in quantitative methods from Harvard School of Public Health (1995) and a PhD in medical epidemiology from KI (2000).  I have been primary investigator (PI) and coordinator of many large research projects aiming at more effective implementation of HIV prevention and treatment in resource-poor health systems and high-risk contexts and subpopulations (young people, HIV discordant couples, slum residents, migrants, men who have sex with men and injecting drug users) in Africa. 

Ophelia Haanyama  

Ophelia Haanyama Ophelia Haanyama is an HIV activist, author, banker and an internationally renowned speaker. She has shared her story of living with HIV with audiences across the world.  Born and raised in Zambia, Ophelia Haanyama moved to Sweden in 1991. She was diagnosed with HIV during a medical consultation while pregnant and has since chronicled her life, including her battle with HIV, in the book, Ophelia’s Journey.  Ophelia Haanyama is currently a senior advisor for Noah’s Ark, a board member for AIDS Action Europe and aid for the European Union’s HIV/AIDS Think Tank. She is also Senior Advisor for the centre of HIV research at karolinska institute. Since 1998, she has been an Ambassador for Star For Life, has a column on Bristol Myers Website. She has also produced a documentary film “Together We Can “ the film was sponsored by Scania, Sandvik and Abbott (ABBVIE) pharmaceutical and was launched in 6 different countries in 3 different continents.  

Joshua Kimani 

Dr. Kimani is a clinical epidemiologist with a Medical Degree from the University of Nairobi and a Masters of Public Health (Epidemiology) from the University of Washington, Seattle.  He is currently the Clinical Research Director at the University of Manitoba field office in Kenya, implementing HIV research activities in collaboration with researchers from the University of Nairobi. His research interests include the epidemiology and immunobiology of STIs among sex workers, mechanisms of HIV resistance, reproductive health, novel HIV prevention strategies e.g. TASP and PrEP and he has also become interested in global health ethics. In the last 10 years, Dr. Kimani has also been serving as a Co- Director for their CDC funded program:-  “Increasing Access to Quality Comprehensive HIV Prevention Services for Most-At-Risk Populations (MARPs) in Nairobi Province, Kenya”. This program is currently providing comprehensive HIV prevention, care and treatment services to at least 20000 sex workers residing within Nairobi County.

Kristina Broliden

Kristina BrolidenKristina Broliden is a professor and senior consultant in Infectious Diseases at the Karolinska Institutet and the Karolinska University Hospital in Stockholm. Her research interests include the mucosal immunology of HIV among men and women at high risk of HIV infection. A better understanding of molecular markers of HIV susceptibility can gain insight into future preventative therapies. She has worked in the context of large clinical cohorts in Kenya and Sweden during the past 20 years. During the last year, Dr. Broliden has participated in a NIH-funded program "Griffithsin-based rectal microbicides for the prevention of viral entry" in collaboration with the University of Louisville, USA. This project aims at developing a prophylactic compound for topical use against sexual HIV transmission.